The Journal of Allergy and Clinical Immunology: In Practice
Volume 9, Issue 6, June 2021, Pages 2541-2542
Correspondence and ReplyReply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
Cited by (0)
C. L. Haga has received funding from the Schacknow Family Foundation, Inc and previously served as a consultant for the purification of adenovirus-based therapeutics including vaccines for various companies. The rest of the authors declare that they have no relevant conflicts of interest.
© 2021 American Academy of Allergy, Asthma & Immunology